Aimo Harmoinen

2.8k total citations
92 papers, 2.1k citations indexed

About

Aimo Harmoinen is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aimo Harmoinen has authored 92 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Nephrology, 17 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aimo Harmoinen's work include Chronic Kidney Disease and Diabetes (15 papers), Pancreatitis Pathology and Treatment (9 papers) and Renal Diseases and Glomerulopathies (9 papers). Aimo Harmoinen is often cited by papers focused on Chronic Kidney Disease and Diabetes (15 papers), Pancreatitis Pathology and Treatment (9 papers) and Renal Diseases and Glomerulopathies (9 papers). Aimo Harmoinen collaborates with scholars based in Finland, Netherlands and Italy. Aimo Harmoinen's co-authors include Amos Pasternack, Terho Lehtimäki, K Pietilä, Jaakko Hartiala, Olli T. Raitakari, P Grönroos, Jukka Mustonen, Heikki Saha, Jorma Viikari and Mikko J. Järvisalo and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Aimo Harmoinen

88 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aimo Harmoinen Finland 24 582 491 408 404 262 92 2.1k
Martino Laurenzi Italy 24 588 1.0× 338 0.7× 205 0.5× 506 1.3× 457 1.7× 58 2.1k
Gültekin Süleymanlar Türkiye 26 480 0.8× 234 0.5× 480 1.2× 746 1.8× 391 1.5× 128 2.3k
Rocco C. Venuto United States 25 328 0.6× 193 0.4× 292 0.7× 455 1.1× 246 0.9× 103 2.1k
Per‐Eric Evrin Sweden 25 372 0.6× 346 0.7× 201 0.5× 561 1.4× 397 1.5× 37 3.0k
Richard A. Robson New Zealand 29 225 0.4× 489 1.0× 513 1.3× 348 0.9× 173 0.7× 87 2.8k
Charles Turner United Kingdom 31 223 0.4× 505 1.0× 335 0.8× 743 1.8× 269 1.0× 87 2.6k
Michał Nowicki Poland 27 557 1.0× 345 0.7× 483 1.2× 761 1.9× 392 1.5× 221 2.9k
Katharine A. Kirk United States 24 862 1.5× 168 0.3× 323 0.8× 1.0k 2.6× 414 1.6× 51 2.5k
Guido O. Pérez United States 25 512 0.9× 315 0.6× 305 0.7× 511 1.3× 560 2.1× 108 2.1k
Leonard G. Feld United States 20 274 0.5× 193 0.4× 368 0.9× 593 1.5× 365 1.4× 65 2.0k

Countries citing papers authored by Aimo Harmoinen

Since Specialization
Citations

This map shows the geographic impact of Aimo Harmoinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimo Harmoinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimo Harmoinen more than expected).

Fields of papers citing papers by Aimo Harmoinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimo Harmoinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimo Harmoinen. The network helps show where Aimo Harmoinen may publish in the future.

Co-authorship network of co-authors of Aimo Harmoinen

This figure shows the co-authorship network connecting the top 25 collaborators of Aimo Harmoinen. A scholar is included among the top collaborators of Aimo Harmoinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimo Harmoinen. Aimo Harmoinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harmoinen, Aimo. (2012). Evaluation and improvement of clinical chemical laboratory tests for glomerular function. Trepo - Institutional Repository of Tampere University.
2.
Järvelä, Kati, Pasi Maaranen, Aimo Harmoinen, Heini Huhtala, & Tero Sisto. (2011). Cystatin C in Diabetics as a Marker of Mild Renal Insufficiency after CABG. Annals of Thoracic and Cardiovascular Surgery. 17(3). 277–282. 6 indexed citations
3.
Puolakka, Pia A., Arvi Yli‐Hankala, Tiina Luukkaala, et al.. (2009). The Effect of Parecoxib on Kidney Function at Laparoscopic Hysterectomy. Renal Failure. 31(4). 284–289. 7 indexed citations
4.
Kaartinen, Kati, Onni Niemelä, Jaana Syrjänen, et al.. (2009). Alcohol Consumption and Kidney Function in IgA Glomerulonephritis. Nephron Clinical Practice. 112(2). c86–c93. 10 indexed citations
5.
Mäkelä, Satu, Ilpo Ala‐Houhala, Kaj Groundstroem, et al.. (2008). More than half of the patients with acute Puumala hantavirus infection have abnormal cardiac findings. Scandinavian Journal of Infectious Diseases. 41(1). 57–62. 30 indexed citations
6.
Kaartinen, Kati, Jaana Syrjänen, Ilkka Pörsti, et al.. (2007). Inflammatory markers and the progression of IgA glomerulonephritis. Nephrology Dialysis Transplantation. 23(4). 1285–1290. 21 indexed citations
7.
Ojala, Riitta, Marja Ala‐Houhala, Aimo Harmoinen, et al.. (2005). Tubular proteinuria in pre-term and full-term infants. Pediatric Nephrology. 21(1). 68–73. 14 indexed citations
8.
Sanders, Gerard T., J R McMurray, V. Blaton, et al.. (2004). The European Register for Specialists in Clinical Chemistry and Laboratory Medicine: Code ofConduct. Clinical Chemistry and Laboratory Medicine (CCLM). 42(5). 563–5. 4 indexed citations
9.
Ala‐Houhala, Marja, et al.. (2004). Renal impairment and hypertension in brain tumor patients treated in childhood are mainly associated with cisplatin treatment. Pediatric Blood & Cancer. 44(4). 363–369. 23 indexed citations
10.
Gurr, Eberhard, Ursula Köller, V. Blaton, et al.. (2003). The European Register for Specialists in Clinical Chemistry and Laboratory Medicine: Guide to the Register Version 2-2003 and Procedure for Re-registration. Clinical Chemistry and Laboratory Medicine (CCLM). 41(2). 238–47. 9 indexed citations
11.
12.
Harmoinen, Aimo, Elisa Ylinen, M Ala-Houhala, et al.. (2000). Reference intervals for cystatin C in pre- and full-term infants and children. Pediatric Nephrology. 15(1-2). 105–108. 83 indexed citations
13.
Rinne, Timo, Aimo Harmoinen, & Seppo Kaukinen. (2000). Esmolol cardioplegia in unstable coronary revascularisation patients. Acta Anaesthesiologica Scandinavica. 44(6). 727–732. 8 indexed citations
14.
Räty, Sari, Juhani Sand, Seppo Laine, Aimo Harmoinen, & Isto Nordback. (1999). Cholecystokinin in the early course of acute post-ERCP pancreatitis. Journal of the American College of Surgeons. 189(6). 560–565. 3 indexed citations
15.
Leinonen, Janne, Hannu Alho, Aimo Harmoinen, Terho Lehtimäki, & Mikael Knip. (1998). Unaltered antioxidant activity of plasma in subjects at increased risk for IDDM. Free Radical Research. 29(2). 159–164. 9 indexed citations
16.
17.
Sisto, Tero, Hannu Paajanen, T. Metsä‐Ketelä, et al.. (1995). Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. The Annals of Thoracic Surgery. 59(6). 1519–1523. 69 indexed citations
18.
Pietilä, K, Aimo Harmoinen, W.Th. Hermens, et al.. (1993). Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. European Heart Journal. 14(7). 915–919. 86 indexed citations
19.
Pasanen, Matti, et al.. (1992). Evaluation of hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate. Critical Care Medicine. 20(3). 378–386. 45 indexed citations
20.
Pietilä, K, Aimo Harmoinen, & Anna‐Maija Teppo. (1991). Acute Phase Reaction, Infarct Size and In-Hospital Morbidity in Myocardial Infarction Patients Treated With Streptokinase or Recombinant Tissue Type Plasminogen Activator. Annals of Medicine. 23(5). 529–535. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martino Laurenzi Breakdown of academic impact, for papers by Gültekin Süleymanlar Breakdown of academic impact, for papers by Rocco C. Venuto Breakdown of academic impact, for papers by Per‐Eric Evrin Breakdown of academic impact, for papers by Richard A. Robson Breakdown of academic impact, for papers by Charles Turner Breakdown of academic impact, for papers by Michał Nowicki Breakdown of academic impact, for papers by Katharine A. Kirk Breakdown of academic impact, for papers by Guido O. Pérez Breakdown of academic impact, for papers by Leonard G. Feld
Rankless by CCL
2026